Major Trial Finds No Benefit of Ivermectin in Preventing Hospitalization
A landmark international clinical trial has concluded that Ivermectin, a drug long touted by some as a COVID-19 remedy, doesn’t reduce hospitalization rates among infected patients. The results, based on a large randomized trial conducted across multiple countries, further confirm the lack of clinical benefit for Ivermectin in the battle against COVID-19. Despite...
0 Comments 0 Shares 187 Views 0 Reviews
Sponsored